Drugs / NM21-1480
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04442126 | Aug 2020 → Feb 2024 | colorectal cancer, fallopian tube carcinoma, head and neck squamous cell carcinoma, non-small cell lung carcinoma +3 | Numab Therapeutics AG | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NM21-1480 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04442126 ↗ |